title: Re: Dyslipidemia is a protective factor in amyotrophic lateral sclerosis.
authors.forename: Y
authors.initials: Y
authors.lastname: Yoshii
authors.forename: K
authors.initials: K
authors.lastname: Ikeda
authors.forename: K
authors.initials: K
authors.lastname: Iwamoto
authors.forename: Y
authors.initials: Y
authors.lastname: Kawase
authors.forename: Y
authors.initials: Y
authors.lastname: Iwasaki
mesh_terms: D000690:Amyotrophic Lateral Sclerosis / Q000150:complications* / Q000378:metabolism*; D000818:Animals; D050171:Dyslipidemias / Q000150:complications* / Q000378:metabolism*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D000960:Hypolipidemic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D051379:Mice; D008818:Mice, Neurologic Mutants; D009119:Muscle Contraction / Q000502:physiology; D018696:Neuroprotective Agents; D013045:Species Specificity
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D018696:Neuroprotective Agents